Cytokines in thyroid autoimmunity

Autoimmunity

Volumn 36, Issue 6-7, 2003, Pages 351-359

  Ajjan, Ramzi A ^a   Weetman, A P ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Autoimmune hypothyroidism; Autoimmune thyroid disease; Cytokines; Graves' disease; Interleukins; Thyroid associated ophthalmopathy

Indexed keywords

ALPHA INTERFERON; ANTITHYROID AGENT; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; IODINE; RANTES; THIAMAZOLE; THYROID HORMONE; THYROXINE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CANCER; CELL FUNCTION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG EFFECT; EXOPHTHALMOS; EYE DISEASE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IN VIVO STUDY; INFLAMMATION; MULTIPLE SCLEROSIS; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; THYROID DISEASE; THYROID GLAND; THYROID HORMONE SYNTHESIS; THYROID SURGERY;

CYTOKINES; FIBROBLASTS; GRAVES DISEASE; HUMANS; LYMPHOCYTES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0141705416     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930310001603046     Document Type: Review

References (53)

1. Prete, D. (1998) "The concept of type 1 and type 2 helper T cells and their cytokines in humans", Int. Rev. Immunol. 16, 427-455.
2. Prud'homme, G.J. and Piccirillo, C.A. (2000) "The inhibitory effects of transforming growth factor-beta-1 in autoimmune diseases", J. Autoimmun. 14, 23-42.
3. Ajjan, R.A., Watson, P.F. and Weetman, A.P. (1996) "Cytokines and thyroid function", Adv. Neuroimmunol. 6, 359-386.
4. Azmi, N., Ajjan, R.A., Findlay, C., Watson, P.F. and Weetman, A.P. (1997) "The detection of IL-14, IL-16 and IL-17 mRNA in the thyroid of patients with autoimmune thyroid disease", J. Endocrinol. 155(Suppl.), P74.
5. Ashhab, Y., Dominguez, O., Sospedra, M., Roura-Mir, C., Lucas-Martin, A. and Pujol-Borrell, R. (1999) "A one-tube polymerase chain reaction protocol demonstrates CC chemokine overexpression in Graves' disease glands", J. Clin. Endocrinol. Metab. 84, 2873-2882.
6. Takiyama, Y., Miyokawa, N., Tokusashi, Y., et al. (2002) "Thyroid-stimulating hormone induces interleukin-18 gene expression in FRTL-5 cells: Immunohistochemical detection of interleukin-18 in autoimmune thyroid disease", Thyroid 12, 935-943.
7. Heuer, M., Aust, G., Ode-Hakim, S. and Scherbaum, W.A. (1996) "Different cytokine mRNA profile in Graves' disease, Hashimoto's thyroiditis, and non autoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR)", Thyroid 6, 97-105.
8. De La Vega, J.R., Vilaplana, J.C., Biro, A., Hammond, L., Bottazzo, G.F. and Mirakian, R. (1998) "IL-10 expression in thyroid glands: Protective or harmful role against thyroid autoimmunity?", Clin. Exp. Immunol. 113, 126-135.
9. Ajjan, R.A. and Weetman, A.P. (2000) In: Rapoport, B. and McLachlan, S., eds, Graves' Disease: Pathogenesis and Treatment (Kluwer Academic Publishers, Norwell, Massachusetts, USA), pp 79-93.
10. Hiromatsu, Y., Yang, D., Bednarczuk, T., Miyake, I., No, K. and Inoue, Y. (2000) "Cytokine profile in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy", J. Clin. Endocrinol. Metab. 85, 1194-1199.
11. Wakelkamp, I.M., Bakker, O., Baldeschi, L., Wiersinga, W.M. and Prummel, M.F. (2003) "TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients", Clin. Endocrinol. 58, 280-287.
12. Roura-Mir, C., Catalfamo, M., Sospedra, M., Alcalde, L., Pujol-Borrell, R. and Jaraquemada, D. (1997) "Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease", Eur. J. Immunol. 27, 3290-3302.
13. Okumura, M., Hidaka, Y., Matsuzuka, F., et al. (1999) "CD30 expression and interleukin-4 and interferon-γ production of intrathyroidal lymphocytes in Graves' disease", Thyroid 9, 333-339.
14. Lopez-Garcia, M.A., Sancho, D., Sanchez-Madrid, F. and Marazuela, M. (2001) "Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes", J. Clin. Endocrinol. Metab. 86, 5008-5016.
15. Aniszewski, J.P., Valyasevi, R.W. and Bahn, R.S. (2000) "Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy", J. Clin. Endocrinol. Metab. 85, 776-780.
16. Yang, D., Hiromatsu, Y., Hoshino, T., Inoue, Y., Itoh, K. and Nonaka, K. (1999) "Dominant infiltration of T(H)1-type CD4+T cells at the retrobulbar space of patients with thyroid-associated ophthalmopathy", Thyroid 9, 305-310.
17. Koumas, L., Smith, T.J. and Phipps, R.P. (2002) "Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes", Eur. J. Immunol. 32, 477-485.
18. Pritchard, J., Horst, N., Cruikshank, W. and Smith, T.J. (2002) "Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts", J. Immunol. 168, 942-950.
19. Mühlberg, T., Joba, W., Spitzweg, C., Schworm, H-D., Heberling, H-J. and Heufelder, A.E. (2000) "Interleukin-1 receptor antagonist RNA and protein expression by cultured Graves' and normal orbital fibroblasts is differentially modulated by dexamethasone and irradiation", J. Clin. Endocrinol. Metab. 85, 734-742.
20. Metcalfe, R.A., McIntosh, R.S., Marelli-Berg, F., Lombardi, G., Lechler, R. and Weetman, A.P. (1998) "Detection of CD40 on human thyroid follicular cells: Analysis of expression and function", J. Clin. Endocrinol. Metab. 83, 1268-1274.
21. Paolieri, F., Salmaso, C., Battifora, M., et al. (1999) "Possible pathogenic relevance of interleukin-1 beta in destructive organ-specific autoimmune disease (Hashimoto's thyroiditis)", Ann. NY Acad. Sci. 876, 221-228.
22. Weetman, A.P. (2003) "Autoimmune thyroid disease: Propagation and progression", Eur. J. Endocrinol. 148, 1-9.
23. Palazzo, F.F., Hammond, L.J., Goode, A.W. and Mirakian, R. (2000) "Death of the autoimmune thyrocyte: Is it pushed or does it jump?", Thyroid 10, 561-572.
24. Heufelder, A.E. (2000) "Pathogenesis of ophthalmopathy in autoimmune thyroid disease", Rev. Endocrinol. Metab. Disord. 1, 87-95.
25. Jyonouchi, S.C., Valyasevi, R.W., Harteneck, D.A., Dutton, C.M. and Bahn, R.S. (2001) "Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy", Thyroid 11, 929-934.
26. Bahn, R.S. (2002) "Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy", Thyroid 12, 193-195.
27. Valyasevi, R.W., Jyonouchi, S.C., Dutton, C.M., Munsakul, N. and Bahn, R.S. (2001) "Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts", J. Clin. Endocrinol. Metab. 86, 501-503.
28. Molnar, I. and Balazs, C. (1997) "High circulating IL-6 level in Graves' ophthalmopathy", Autoimmunity 25, 91-96.
29. Nishikawa, T., Yamashita, S., Namba, H., et al. (1993) "Interferon-γ inhibition of human thyrotropin receptor gene expression", J. Clin. Endocrinol. Metab. 77, 1084-1089.
30. Ajjan, R.A., Kammarudin, N.A., Crisp, M., Watson, P.F., Ludgate, M. and Weetman, A.P. (1998) "Regulation and tissue distribution of the human sodium iodide symporter gene", Clin. Endocrinol. 49, 517-523.
31. Schumm-Draeger, P.M. (2001) "Sodium/iodide symporter (NIS) and cytokines", Exp. Clin. Endocrinol. Diabetes 109, 32-34.
32. Rasmussen, A.K., Kayser, L., Rasmussen, U.F. and Bendtzen, K. (1994) "Influence of tumour necrosis factor-β and interferon-γ, separately and added together with interleukin-1β, on the function of cultured human thyroid cells", J. Endocrinol. 143, 359-365.
33. Wang, L., Teng, W. and Shan, Z. (2000) "Effect of IFN-gamma, IL-4 on proliferation and synthesis of hyaluronic acid and collagen in cultured human retroorbital fibroblasts in vitro", Chin. Med. J. 113, 907-910.
34. Koh, L.K.H., Greenspan, F.S. and Yeo, P.P.B. (1998) "Interferon-α-induced thyroid dysfunction: Three clinical presentations and a review of the literature", Thyroid 8, 891-896.
35. Carella, C., Mazziotti, G., Morisco, F., et al. (2001) "Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment", J. Clin. Endocrinol. Metab. 86, 1925-1929.
36. Monzani, F., Caraccio, N., Meucci, G., et al. (1999) "Effect of 1-year treatment with interferon-β1b on thyroid function and autoimmunity in patients with multiple sclerosis", Eur. J. Endocrinol. 141, 325-331.
37. Durelli, L., Ferrero, B., Ogerro, A., et al. (2001) "Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for multiple sclerosis", Neurology 57, 1363-1370.
38. De Metz, J., Romijn, J.I., Endert, E., Crossmit, E.P. and Sauerwein, H.P. (2000) "Administration of interferon-gamma in healthy subjects does not modulate thyroid hormone metabolism", Thyroid 10, 87-91.
39. Torpy, D.J., Tsigos, C., Lotsikas, A.J., et al. (1998) "Acute and delayed effects of a single dose injection of IL-6 on thyroid function in healthy humans", Metabolism 47, 1289-1293.
40. Binaghi, M., Levy, C., Douvin, C., Guittard, M., Soubrane, G. and Coscas, G. (2002) "Severe thyroid ophthalmopathy related to interferon alpha therapy", J. Fr. Ophthalmol. 25, 412-415.
41. Imagawa, A., Itoh, N., Hanafusa, T., et al. (1995) "Autoimmune endocrine disease induced by recombinant IFN-α therapy for chronic active type C hepatitis", J. Clin. Endocrinol. Metab. 80, 922-926.
42. Hidaka, Y., Okumura, M., Shimaoka, Y., Takeoka, K., Tada, H. and Amino, N. (1998) "Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis", Thyroid 8, 235-239.
43. Al-Humaidi, M.A. (2000) "Serum cytokine levels in Graves' disease", Saudi Med. J. 7, 639-644.
44. Bossowski, A. and Urban, M. (2001) "Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic goiter", J. Pediatr. Endocrinol. Metab. 14, 741-747.
45. Tamaru, M., Matsuura, B. and Onji, M. (1999) "Increased levels of interleukin-12 in Graves' disease", Eur. J. Endocrinol. 141, 111-116.
46. Miyauchi, S., Matsuura, B. and Onji, M. (2000) "Increased levels of serum interleukin-18 in Graves' disease", Thyroid 10, 815-819.
47. Komiya, I., Amada, T., Sato, A., Koukie, T., Nishimori, T. and Takasu, N. (2001) "Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13", J. Clin. Endocrinol. Metab. 86, 3540-3544.
48. Maziotti, G., Sorvillo, F., Naclerio, C., et al. (2003) "Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis", Eur. J. Endocrinol. 148, 383-388.
49. Salvi, M., Pedrazzoni, M., Girasole, G., et al. (2000) "Serum concentrations of proinflammatory cytokines in Graves' disease: Effect of treatment, thyroid function, ophthalmopathy and cigarette smoking", Eur. J. Immunol. 143, 197-202.
50. Mysliwiec, J., Kretowiski, A., Topolska, J., et al. (2001) "Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids", Horm. Metab. Res. 33, 739-743.
51. Wakelkamp, I.M., Gerding, M.N., Van Der Meer, J.W., Prummel, M.F. and Wiersinga W.M. (2000) "Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy", Clin. Exp. Immunol. 121, 453-457.
52. Hofbauer, L.C., Muhlberg, T., Konig, A., Heufelder, G., Schworm, H.D. and Heufelder, A.E. (1997) "Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy", J. Clin. Endocrinol. Metab. 82, 2244-2247.
53. Mysliwiec, J., Kretowski, A., Stepien, A., Mironczuk, K. and Kinalska, I. (2003) "Interleukin-18 and transforming growth factor-beta1 in the sera of patients with Graves' ophthalmopathy treated with corticosteroids", Int. Immunopharmacol. 3, 549-552.